Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
To assess initial results and the safety of stem cell and platelet rich plasma in treatment of chronic obstructive pulmonary disease. Subjects and methods: This interventional trial was carried out on 10 chronic obstructive pulmonary disease patients, with the number of patients of group C and D were 2 and 8, respectively, following to GOLD 2018. | Initial results of using mesenchymal stem cell and platelet rich plasma in treatment of chronic obstructive pulmonary disease